1 / 24

Giorgio Arnaldi

Case for androgens. Giorgio Arnaldi. Clinica di Endocrinologia AOU Ospedali Riuniti Ancona Ancona gioarnaldi@gmail.com. Adrenal androgens and bone. Agenda. Physiology of adrenal androgens , i.e. DHEA Effects of adrenal androgens on bone DHEA treatment in post-menopausal women

mpalmer
Download Presentation

Giorgio Arnaldi

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Case forandrogens Giorgio Arnaldi ClinicadiEndocrinologia AOU OspedaliRiunitiAncona Ancona gioarnaldi@gmail.com

  2. Adrenalandrogens and bone Agenda • Physiologyofadrenalandrogens , i.e. DHEA • Effectsofadrenalandrogens on bone • DHEA treatment in post-menopausal women • DHEA treatment and boneeffects in Addison

  3. 10 000 Man DHEAS nmol l-1 Woman 0 10 20 30 40 50 60 70 Fetal Period Age (years) DHEA and DHEAS are the mostabundantsteroids in humans Adult 6-month oldinfant Birth At 50-60 yr, DHEA hasalreadydecreasedby 70% The individualvariabilityacrossadulthoodissubstantial and the normalrangeofserum DHEA(S) isthereforevery wide at each decade of life

  4. DHEA exertsitsprimaryeffectsthroughitsestrogenic and androgenicmetabolites Labrie 2007

  5. A specific DHEA receptorhasnotbeencharacterized Although DHEA maybeconvertedto DHEAS by SULT2A1, no relevantamountsof DHEA resultfromconversionof DHEAS. Therefore, DHEAS levels, which are measured in the routine clinicalpractice, maynotalwaysreflect the amountofavailable DHEA. In women, exogenous DHEA ismainlyconvertedtoandrogens. An increase in serumandrogensisobservedonly in menwith low androgenlevels Lang et al BP&R ClinEndocrinolMetab 2015

  6. Adrenalandrogens and bone Agenda • Physiologyofadrenalandrogens , i.e. DHEA • Effectsofadrenalandrogens on bone • DHEA treatment in post-menopausal women • DHEA treatment and boneeffects in Addison

  7. A specificbone DHEA receptor ?

  8. “Thesefindingssuggestthat the hyperandrogenismobserved in Premature Adrenarchemaydirectly or indirectlyaffectbonemineralmass….”

  9. DHEA and itsmetabolites are independentdeterminantsofcortical density, particularlybefore the activationofpubertal sex hormones • Remer, Tet al. Adrenarche and bonemodeling and remodeling at the proximalradius: weakandrogensmakestrongercorticalbone in healthychildren. Journal ofBone and MineralResearch, 18, 1539–1546. 2003 • DHEAS correlatesnegativelywithbone turnover beforepeak mass • Walsh, J.S.et al Hormonaldeterminantsofbone turnover before and afterattainmentofpeakbone mass. ClinicalEndocrinology (Oxf), 72, 320–327. 2010 • DHEAS, androstenedione and estrone were positive predictorsofboneage (….buttheywerenotassociatedwithbone density) • VandewalleSet al. Relation ofadrenal-derivedsteroidswithbonematuration, mineral density andgeometry in healthyprepubertal and earlypubertalboys. Bone. 69:39-46. 2014

  10. Eighty CAH adults (47 classic, 33 nonclassic) low DHEAS maybeassociatedwithweakcorticalboneindependentofglucocorticoidexposure. • DHEAS was the onlyindependentsignificantpredictorof BMD at the forearm and spine • In a multivariate analysisafteradjustingforage, gender, height standard deviation, phenotype and cumulative glucocorticoidexposure, higher DHEAS wasindependentlyassociatedwithhigher BMD at the spine, radius and whole body.

  11. Adrenalandrogens and bone Agenda • Physiologyofadrenalandrogens , i.e. DHEA • Effectsofadrenalandrogens on bone • DHEA treatment in post-menopausal women • DHEA treatment and boneeffects in Addison

  12. Exogenous DHEA treatment • Whenadministeredtopostmenopausal women, DHEA ismainlytransformedtoandrogensratherthanestrogens. • Usingliquidchromatographycombinedwith tandem mass spectrometry, anoral dose of DHEA 50 mg dailyfor 12 monthsincreases: • estrone 34% and estradiol 57% • total testosterone about 100%, • DHT relativelyunchanged Davis et al JClinEndocrinolMetab, 2011, 96(6):1642–1653

  13. DHEA wasadministeredpercutaneously once daily in the morningas a 10% cream 14 women (60 to 70 yr) Total hip +2% at 12 months Labrieet al JClinEndocrinolMetab, 82:3498–3512, 1997

  14. Effectsof DHEA on bone in postmenopausal women in placebo-controlledtrials The effectissmall in relation toother treatment No fractures data are available Over 26 weeks 640 women Davis et al JClinEndocrinolMetab, 2011, 96(6):1642–1653

  15. Adrenalandrogens and bone Agenda • Physiologyofadrenalandrogens , i.e. DHEA • Effectsofadrenalandrogens on bone • DHEA treatment in post-menopausal women • DHEA treatment and boneeffects in Addison

  16. Adrenalinsufficiency • Replacementtherapy • Glucocorticoid • Mineralocorticoid • (Addisononly) • DHEAS (?) In bothprimary and secondaryadrenalinsufficiency, DHEA secretionisclearlydecreased and oftenevenabsent. In women, itresults in significantandrogendeficiencywhereastesticular testosterone ispreserved in men.

  17. Gurnellet al Double-blind trial, randomized 106 subjects (44 males, 62 females) withAddison’sdiseasetoreceiveeither 50 mg dailyofmicronized DHEA or placebo orallyfor 12 months DHEA reversedongoing loss ofbonemineral density at the femoralneck (P 0.05) butnot at othersites. The improvementwasmodestcomparingother treatment

  18. 10 femalepatients (medianage 38.5 years, range 28–52) withadrenalfailureweretreatedwith DHEA 50 mg for6months in a double-blind, randomized, placebo-controlled, and crossover study

  19. No effects on muscle, fat, and bonetissue and on fuelmetabolism Frequentadverseeffects 10 femalepatients (medianage 38.5 years, range 28–52) withadrenalfailureweretreatedwith DHEA 50 mg for6months in a double-blind, randomized, placebo-controlled, and crossover study

  20. JInternMed. 2014;275:104-15.

More Related